Meghan Fitzgerald

Meghan Fitzgerald

Director/Board Member en ROIVANT SCIENCES LTD. .

Fortuna: 3 M $ al 29/02/2024

53 años
Health Technology
Finance
Consumer Services

Perfil

Meghan M.
Fitzgerald
founded K2 HealthVentures Group LLC and K2 HealthVentures LLC.
Presently, she occupies the position of Senior Advisor at Wellspring Capital Management LLC.
Dr. Fitzgerald is also on the board of Tenet Healthcare Corp., Roivant Sciences Ltd., Seniorlink, Inc. and Quanta Dialysis Technologies Ltd.
and Assistant Professor-Health Policy at The Trustees of Columbia University in The City of New York, Member of Harvard Kennedy School of Government and Advisor at Thimble Point Acquisition Corp.
II.
In her past career she was Chief Executive Officer & Managing Partner at LetterOne Holdings SA, President-Specialty Solutions at Cardinal Health, Inc. and President at Cardinal Health 122 LLC (a subsidiary of Cardinal Health, Inc.), Principal at Merck & Co., Inc., Senior Director-Strategic Planning-Human Health at Pfizer Inc. and Principal at Pfizer Global Pharmaceuticals, Inc. (a subsidiary of Pfizer Inc.), Chief Business Officer & Vice President at Vion Pharmaceuticals, Inc., Managing Partner at Letterone Investment Holdings SARL, Senior VP-New Markets International Division at Medco Health Solutions, Inc. and Principal at Sanofi-Synthelabo, Inc. Meghan M.
Fitzgerald
received an undergraduate degree from Fairfield University, a graduate degree from The Trustees of Columbia University in The City of New York and a doctorate from New York Medical College.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
26/05/2023 35 269 ( 0.04% ) 3 M $ 29/02/2024
19/01/2024 12 686 ( 0.00% ) 145 128 $ 29/02/2024

Cargos activos de Meghan Fitzgerald

EmpresasCargoInicio
TENET HEALTHCARE CORPORATION Director/Board Member 29/05/2018
ROIVANT SCIENCES LTD. Director/Board Member 13/03/2023
Consultant / Advisor -
Director/Board Member 10/01/2022
Corporate Officer/Principal -
The Trustees of Columbia University in The City of New York Corporate Officer/Principal 01/09/2014
Harvard Kennedy School of Government Corporate Officer/Principal -
Director/Board Member -
Todos los cargos activos de Meghan Fitzgerald

Antiguos cargos conocidos de Meghan Fitzgerald.

EmpresasCargoFin
THIE POIN Director/Board Member 01/12/2021
░░░░░░░░░░░ ░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Meghan Fitzgerald.

Formación de Meghan Fitzgerald.

The Trustees of Columbia University in The City of New York Graduate Degree
Fairfield University Undergraduate Degree
New York Medical College Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Meghan Fitzgerald.

Relaciones

100 +

Relaciones de 1er grado

28

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas6
CARDINAL HEALTH, INC.

Distribution Services

MERCK & CO., INC.

Health Technology

PFIZER, INC.

Health Technology

TENET HEALTHCARE CORPORATION

Health Services

ROIVANT SCIENCES LTD.

Health Technology

ARIX BIOSCIENCE PLC

Finance

Empresas privadas18

Health Technology

Finance

Health Services

Health Technology

Health Technology

Health Technology

Sanofi-Synthelabo, Inc.

Health Technology

Consumer Services

Technology Services

Technology Services

Health Technology

Finance

Finance

Process Industries

Finance

K2 HealthVentures LLC

Finance

Finance

Ver las conexiones de la empresa
  1. Bolsa
  2. Insiders
  3. Meghan Fitzgerald